Roche’s experimental drug proved effective in three late-stage studies against multiple sclerosis, potentially heralding an important new treatment option for the debilitating disease.
WSJ.com: Health, Wall Street Journal: Business: Health
Thu, 10/08/2015 - 4:38pm
Roche’s experimental drug proved effective in three late-stage studies against multiple sclerosis, potentially heralding an important new treatment option for the debilitating disease.